ICON PLC Restates Interim Financials, Swings to Massive Loss, Records $465M in Impairments
ICLR sits 74% above its 52-week low of $66.57.
Summary
ICON PLC has filed restated interim financial statements for 2023-2025, revealing a swing to significant losses and over $465 million in asset impairments due to accounting irregularities.
Key Events · Corporate Governance and Compliance · ICLR
-
Massive Financial Restatement
ICON PLC restated unaudited interim financial statements for Q1, Q2, Q3 of 2023, 2024, and 2025 due to improper revenue recognition adjustments and errors in cost estimation.
-
Significant Swing to Net Loss
For the three months ended September 30, 2025, reported net income of $2.355 million was restated to a net loss of $(284.183) million.
-
Major Asset Impairments
The company recorded a $364.2 million goodwill impairment (representing the entire balance of the Data Solutions unit) and a $101.0 million impairment of non-financial assets in the same unit as of September 30, 2025.
-
Accounting Irregularities Confirmed
The restatement stems from an Audit Committee investigation into "improper adjustments" to clinical trial services revenue and errors in cost determination, highlighting severe internal control deficiencies.
Analysis · ICLR · Industrial Applications And Services
This filing details the restatement of ICON PLC's unaudited interim financial statements for multiple quarters across 2023, 2024, and 2025. The restatement, driven by improper revenue recognition adjustments and cost estimation errors, reveals a dramatic shift from reported profits to significant losses. Notably, the three months ended September 30, 2025, saw a reported net income of $2.355 million turn into a net loss of $(284.183) million. Additionally, the company recorded substantial impairments totaling $465.2 million, including a complete write-off of goodwill for its Data Solutions unit. This follows recent disclosures about the Audit Committee's non-reliance on past financials and a Nasdaq non-compliance notice, indicating a severe and ongoing crisis in financial reporting and corporate governance.
How filings like this one have moved
In the 30 days to Aug 26, 2026, 43.5% of the 1024 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.12%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ICLR was trading at $115.50 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $9B. The 52-week trading range was $66.57 to $211.00. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.